Br J Haematol. 2022 Dec 21. doi: 10.1111/bjh.18600. Online ahead of print.
NO ABSTRACT
PMID:36541152 | DOI:10.1111/bjh.18600
Categories
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma XI’, a multicentre, open-label, randomised, phase III trial
